Prevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves’ disease
Purpose The aim of this work was to investigate, in patients with newly diagnosed Graves’ disease (GD), the frequency of islet autoantibodies including autoantibodies against Zink transporter 8 (ZnT8A), as well as to investigate the relation between thyroid autoantibodies, islet autoantibodies and d...
Gespeichert in:
| Veröffentlicht in: | Endocrine Jg. 64; H. 1; S. 48 - 54 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
New York
Springer US
01.04.2019
Springer Nature B.V |
| Schlagworte: | |
| ISSN: | 1355-008X, 1559-0100, 1559-0100 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Purpose
The aim of this work was to investigate, in patients with newly diagnosed Graves’ disease (GD), the frequency of islet autoantibodies including autoantibodies against Zink transporter 8 (ZnT8A), as well as to investigate the relation between thyroid autoantibodies, islet autoantibodies and diabetes both before GD diagnosis and at follow-up.
Methods
Blood samples from 278 patients with newly diagnosed GD were analyzed for autoantibodies against glutamic acid decarboxylase (GADA), insulinoma-associated protein-2 (IA2-A), three variants of zinc transporter 8 (ZnT8A), thyroid peroxidase (TPOA) and the TSH receptor (TRAb). Information on other autoimmune diseases, as well as development of diabetes during follow up was gathered from patient’s medical journal.
Results
At GD diagnosis, 13.7% were positive for islet autoantibodies, with the majority being positive for GADA (8.7%) and ZnT8A (7.6%). TPOA were found positive in 71% and TRAb in 83%. No association was found between islet autoantibodies and thyroid autoantibodies or diabetes diagnosis during follow up. Positive association was found between islet autoantibodies and all forms of diabetes, diagnosed both before and after GD (OR: 2.5, CI: 1.1–6.8,
p
= 0.03) but not to other autoimmune diseases at GD diagnosis.
Conclusions
The incidence of GADA and ZnT8A in patients with GD is high and might indicate wide range endocrine autoimmunity, as well as risk for non-autoimmune diabetes rather than exclusively mark beta cell autoimmunity and type 1 diabetes. |
|---|---|
| AbstractList | PurposeThe aim of this work was to investigate, in patients with newly diagnosed Graves’ disease (GD), the frequency of islet autoantibodies including autoantibodies against Zink transporter 8 (ZnT8A), as well as to investigate the relation between thyroid autoantibodies, islet autoantibodies and diabetes both before GD diagnosis and at follow-up.MethodsBlood samples from 278 patients with newly diagnosed GD were analyzed for autoantibodies against glutamic acid decarboxylase (GADA), insulinoma-associated protein-2 (IA2-A), three variants of zinc transporter 8 (ZnT8A), thyroid peroxidase (TPOA) and the TSH receptor (TRAb). Information on other autoimmune diseases, as well as development of diabetes during follow up was gathered from patient’s medical journal.ResultsAt GD diagnosis, 13.7% were positive for islet autoantibodies, with the majority being positive for GADA (8.7%) and ZnT8A (7.6%). TPOA were found positive in 71% and TRAb in 83%. No association was found between islet autoantibodies and thyroid autoantibodies or diabetes diagnosis during follow up. Positive association was found between islet autoantibodies and all forms of diabetes, diagnosed both before and after GD (OR: 2.5, CI: 1.1–6.8, p = 0.03) but not to other autoimmune diseases at GD diagnosis.ConclusionsThe incidence of GADA and ZnT8A in patients with GD is high and might indicate wide range endocrine autoimmunity, as well as risk for non-autoimmune diabetes rather than exclusively mark beta cell autoimmunity and type 1 diabetes. The aim of this work was to investigate, in patients with newly diagnosed Graves' disease (GD), the frequency of islet autoantibodies including autoantibodies against Zink transporter 8 (ZnT8A), as well as to investigate the relation between thyroid autoantibodies, islet autoantibodies and diabetes both before GD diagnosis and at follow-up. Blood samples from 278 patients with newly diagnosed GD were analyzed for autoantibodies against glutamic acid decarboxylase (GADA), insulinoma-associated protein-2 (IA2-A), three variants of zinc transporter 8 (ZnT8A), thyroid peroxidase (TPOA) and the TSH receptor (TRAb). Information on other autoimmune diseases, as well as development of diabetes during follow up was gathered from patient's medical journal. At GD diagnosis, 13.7% were positive for islet autoantibodies, with the majority being positive for GADA (8.7%) and ZnT8A (7.6%). TPOA were found positive in 71% and TRAb in 83%. No association was found between islet autoantibodies and thyroid autoantibodies or diabetes diagnosis during follow up. Positive association was found between islet autoantibodies and all forms of diabetes, diagnosed both before and after GD (OR: 2.5, CI: 1.1-6.8, p = 0.03) but not to other autoimmune diseases at GD diagnosis. The incidence of GADA and ZnT8A in patients with GD is high and might indicate wide range endocrine autoimmunity, as well as risk for non-autoimmune diabetes rather than exclusively mark beta cell autoimmunity and type 1 diabetes. Purpose The aim of this work was to investigate, in patients with newly diagnosed Graves’ disease (GD), the frequency of islet autoantibodies including autoantibodies against Zink transporter 8 (ZnT8A), as well as to investigate the relation between thyroid autoantibodies, islet autoantibodies and diabetes both before GD diagnosis and at follow-up. Methods Blood samples from 278 patients with newly diagnosed GD were analyzed for autoantibodies against glutamic acid decarboxylase (GADA), insulinoma-associated protein-2 (IA2-A), three variants of zinc transporter 8 (ZnT8A), thyroid peroxidase (TPOA) and the TSH receptor (TRAb). Information on other autoimmune diseases, as well as development of diabetes during follow up was gathered from patient’s medical journal. Results At GD diagnosis, 13.7% were positive for islet autoantibodies, with the majority being positive for GADA (8.7%) and ZnT8A (7.6%). TPOA were found positive in 71% and TRAb in 83%. No association was found between islet autoantibodies and thyroid autoantibodies or diabetes diagnosis during follow up. Positive association was found between islet autoantibodies and all forms of diabetes, diagnosed both before and after GD (OR: 2.5, CI: 1.1–6.8, p = 0.03) but not to other autoimmune diseases at GD diagnosis. Conclusions The incidence of GADA and ZnT8A in patients with GD is high and might indicate wide range endocrine autoimmunity, as well as risk for non-autoimmune diabetes rather than exclusively mark beta cell autoimmunity and type 1 diabetes. The aim of this work was to investigate, in patients with newly diagnosed Graves' disease (GD), the frequency of islet autoantibodies including autoantibodies against Zink transporter 8 (ZnT8A), as well as to investigate the relation between thyroid autoantibodies, islet autoantibodies and diabetes both before GD diagnosis and at follow-up.PURPOSEThe aim of this work was to investigate, in patients with newly diagnosed Graves' disease (GD), the frequency of islet autoantibodies including autoantibodies against Zink transporter 8 (ZnT8A), as well as to investigate the relation between thyroid autoantibodies, islet autoantibodies and diabetes both before GD diagnosis and at follow-up.Blood samples from 278 patients with newly diagnosed GD were analyzed for autoantibodies against glutamic acid decarboxylase (GADA), insulinoma-associated protein-2 (IA2-A), three variants of zinc transporter 8 (ZnT8A), thyroid peroxidase (TPOA) and the TSH receptor (TRAb). Information on other autoimmune diseases, as well as development of diabetes during follow up was gathered from patient's medical journal.METHODSBlood samples from 278 patients with newly diagnosed GD were analyzed for autoantibodies against glutamic acid decarboxylase (GADA), insulinoma-associated protein-2 (IA2-A), three variants of zinc transporter 8 (ZnT8A), thyroid peroxidase (TPOA) and the TSH receptor (TRAb). Information on other autoimmune diseases, as well as development of diabetes during follow up was gathered from patient's medical journal.At GD diagnosis, 13.7% were positive for islet autoantibodies, with the majority being positive for GADA (8.7%) and ZnT8A (7.6%). TPOA were found positive in 71% and TRAb in 83%. No association was found between islet autoantibodies and thyroid autoantibodies or diabetes diagnosis during follow up. Positive association was found between islet autoantibodies and all forms of diabetes, diagnosed both before and after GD (OR: 2.5, CI: 1.1-6.8, p = 0.03) but not to other autoimmune diseases at GD diagnosis.RESULTSAt GD diagnosis, 13.7% were positive for islet autoantibodies, with the majority being positive for GADA (8.7%) and ZnT8A (7.6%). TPOA were found positive in 71% and TRAb in 83%. No association was found between islet autoantibodies and thyroid autoantibodies or diabetes diagnosis during follow up. Positive association was found between islet autoantibodies and all forms of diabetes, diagnosed both before and after GD (OR: 2.5, CI: 1.1-6.8, p = 0.03) but not to other autoimmune diseases at GD diagnosis.The incidence of GADA and ZnT8A in patients with GD is high and might indicate wide range endocrine autoimmunity, as well as risk for non-autoimmune diabetes rather than exclusively mark beta cell autoimmunity and type 1 diabetes.CONCLUSIONSThe incidence of GADA and ZnT8A in patients with GD is high and might indicate wide range endocrine autoimmunity, as well as risk for non-autoimmune diabetes rather than exclusively mark beta cell autoimmunity and type 1 diabetes. Purpose: The aim of this work was to investigate, in patients with newly diagnosed Graves’ disease (GD), the frequency of islet autoantibodies including autoantibodies against Zink transporter 8 (ZnT8A), as well as to investigate the relation between thyroid autoantibodies, islet autoantibodies and diabetes both before GD diagnosis and at follow-up. Methods: Blood samples from 278 patients with newly diagnosed GD were analyzed for autoantibodies against glutamic acid decarboxylase (GADA), insulinoma-associated protein-2 (IA2-A), three variants of zinc transporter 8 (ZnT8A), thyroid peroxidase (TPOA) and the TSH receptor (TRAb). Information on other autoimmune diseases, as well as development of diabetes during follow up was gathered from patient’s medical journal. Results: At GD diagnosis, 13.7% were positive for islet autoantibodies, with the majority being positive for GADA (8.7%) and ZnT8A (7.6%). TPOA were found positive in 71% and TRAb in 83%. No association was found between islet autoantibodies and thyroid autoantibodies or diabetes diagnosis during follow up. Positive association was found between islet autoantibodies and all forms of diabetes, diagnosed both before and after GD (OR: 2.5, CI: 1.1–6.8, p = 0.03) but not to other autoimmune diseases at GD diagnosis. Conclusions: The incidence of GADA and ZnT8A in patients with GD is high and might indicate wide range endocrine autoimmunity, as well as risk for non-autoimmune diabetes rather than exclusively mark beta cell autoimmunity and type 1 diabetes. |
| Author | Jonsdottir, Berglind Jönsson, Ida Lantz, Mikael |
| Author_xml | – sequence: 1 givenname: Berglind orcidid: 0000-0003-4129-1767 surname: Jonsdottir fullname: Jonsdottir, Berglind email: berglind.jonsdottir@gmail.com organization: Department of Endocrinology, Lund University, Department of Clinical Sciences, Skåne University Hospital – sequence: 2 givenname: Ida surname: Jönsson fullname: Jönsson, Ida organization: Department of Endocrinology, Lund University, Department of Clinical Sciences, Skåne University Hospital – sequence: 3 givenname: Mikael surname: Lantz fullname: Lantz, Mikael organization: Department of Endocrinology, Lund University, Department of Clinical Sciences, Skåne University Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30783963$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UsluFDEQbaEgssAPcEAtceHS4LXbfUFCEQSkSHAAiZvlpXriyGMPdvcM4cRvcOHj-BLcM5NAcsjB8lLv1asqv-PqIMQAVfUUo5cYoe5VxgQR1CDclyU4aTYPqiPM-XxF6KCcKecNQuLrYXWc8yVChJC2e1QdUtQJ2rf0qPr9KcFaeQgG6jjU1ikNI-RaBVuvEuTrgJrGqMLodLRuDi-UC3msf7hg6jGpkFcxjZBqsWUu_DSqpTO1BaOSjt-vvMpQq3EWWISY3U6hPAzR-7ipp9WscpbUGvKfn78KLkOhPK4eDspneLLfT6ov795-Pn3fnH88-3D65rwxvGVjwxjiwkKve90C75mwWtiBamqA9qS1jBuNrCG2a1tMO41423MOmGJuqNGYnlRqlzdvYDVpuUpuqdKVjMrJuTPl5TwMlcyF9JPMIAvKO6NGF0OWBDFooesk5wYkG1otBe2sNB0fuh6s5aorGq93GoW6BGsglMH521K3IsFdyEVcy5ZxhgQqCV7sE6T4bYI8yqXLBrxXAeJUqsCCYSpELwr0-R3oZZxSKCOUhCDOWswZK6hn_1d0U8q1PQqA7AAmxZwTDDcQjOTsQbnzoCwelFsPyk0hiTsk48btoEpXzt9PpftvKDphAelf2few_gJfAvdG |
| CitedBy_id | crossref_primary_10_1016_j_jtemb_2019_126430 crossref_primary_10_1089_thy_2021_0170 crossref_primary_10_1111_cen_14304 crossref_primary_10_3390_ijms241210012 crossref_primary_10_1097_IOP_0000000000002449 |
| Cites_doi | 10.1007/BF00408469 10.1046/j.1365-2796.1996.417758000.x 10.1016/j.jim.2011.06.011 10.1055/s-0033-1363193 10.1001/jama.2013.6285 10.1530/EJE-13-0901 10.1038/347151a0 10.2337/dc15-1419 10.1210/jc.2012-4309 10.1056/NEJMra030158 10.1007/s12020-013-0032-x 10.2337/diabetes.48.3.460 10.1590/2359-3997000000280 10.1210/jc.2009-0747 10.1073/pnas.0705894104 10.1007/s00125-015-3514-y 10.1007/s00125-018-4605-3 10.1016/j.numecd.2008.09.004 10.1210/jcem-51-4-863 10.1007/s00125-013-2934-9 10.4239/wjd.v6.i1.67 10.1172/JCI118188 10.2337/diabetes.51.5.1346 10.1111/eci.12404 10.1046/j.1365-2249.2001.01668.x 10.1530/eje.0.1370503 10.1016/j.metabol.2010.07.025 10.1016/S2213-8587(18)30051-2 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019 Copyright Springer Nature B.V. 2019 |
| Copyright_xml | – notice: The Author(s) 2019 – notice: Copyright Springer Nature B.V. 2019 |
| CorporateAuthor | Lunds universitet Profile areas and other strong research environments Translational Muscle Research Department of Clinical Sciences, Malmö Lund University Translationell muskelforskning Strategiska forskningsområden (SFO) EXODIAB: Excellence of Diabetes Research in Sweden Faculty of Medicine Strategic research areas (SRA) Medicinska fakulteten Pediatrisk endokrinologi Profilområden och andra starka forskningsmiljöer Institutionen för kliniska vetenskaper, Malmö Paediatric Endocrinology |
| CorporateAuthor_xml | – name: Faculty of Medicine – name: Medicinska fakulteten – name: Strategiska forskningsområden (SFO) – name: Translationell muskelforskning – name: Institutionen för kliniska vetenskaper, Malmö – name: Strategic research areas (SRA) – name: Lunds universitet – name: Translational Muscle Research – name: Profilområden och andra starka forskningsmiljöer – name: Paediatric Endocrinology – name: Lund University – name: EXODIAB: Excellence of Diabetes Research in Sweden – name: Profile areas and other strong research environments – name: Pediatrisk endokrinologi – name: Department of Clinical Sciences, Malmö |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 5PM ADTPV AGCHP AOWAS D8T D95 ZZAVC |
| DOI | 10.1007/s12020-019-01852-w |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SWEPUB Lunds universitet full text SwePub Articles SWEPUB Freely available online SWEPUB Lunds universitet SwePub Articles full text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1559-0100 |
| EndPage | 54 |
| ExternalDocumentID | oai_portal_research_lu_se_publications_204e6e77_55ce_4f6b_837d_c75f79edd5a7 PMC6454080 30783963 10_1007_s12020_019_01852_w |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Sk?nes universitetssjukhus grantid: . funderid: http://dx.doi.org/10.13039/501100011077 – fundername: Medicinska Fakulteten, Lunds Universitet grantid: 0 funderid: http://dx.doi.org/10.13039/501100006738 – fundername: Medicinska Fakulteten, Lunds Universitet grantid: 0 – fundername: Sk?nes universitetssjukhus grantid: . – fundername: ; grantid: . – fundername: ; grantid: 0 |
| GroupedDBID | --- -53 -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 203 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 4.4 406 408 40E 53G 5GY 5VS 78A 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACCUX ACDTI ACGFO ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACSNA ACZOJ ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHSBF AIAGR AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BGNMA C6C CS3 CSCUP DDRTE DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 HF~ HG6 HMJXF HRMNR IJ- IKXTQ IMOTQ IWAJR IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y MA- N9A NF0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OVD P19 P2P P9S PF0 PT4 PT5 QOK QOR QOS R89 R9I RHV ROL RPX RSV S16 S27 S37 S3B SAP SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z7U Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX ~KM -Y2 .GJ 2.D 28- 2VQ 7X2 7X7 88E 8FI 8FJ AANXM AAPKM AARHV AAYTO AAYXX ABBRH ABDBE ABFSG ABQSL ABRTQ ABUWG ACSTC ACUDM ADHKG AEBTG AEKMD AEZWR AFDZB AFEXP AFFHD AFHIU AFKRA AFOHR AGGDS AGQPQ AHKAY AHPBZ AHWEU AI. AIXLP AJBLW ATCPS ATHPR AYFIA BBNVY BBWZM BENPR BHPHI BSONS CAG CCPQU CITATION COF FEDTE FYUFA GRRUI H13 HCIFZ HMCUK HVGLF HZ~ M0K M1P M7P N2Q NAPCQ NDZJH O9- PHGZM PHGZT PJZUB PPXIY PQGLB PSQYO R4E RNI RZK S1Z S26 S28 SCLPG T16 TEORI UKHRP VH1 ZXP CGR CUY CVF ECM EIF NPM K9. 7X8 5PM ADTPV AGCHP AOWAS D8T D95 ZZAVC |
| ID | FETCH-LOGICAL-c564t-44058de9b9b6e5948db8df3b3ce3926d45cb0dc2d766137b056955e1315c3cb13 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 8 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000463986100006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1355-008X 1559-0100 |
| IngestDate | Tue Nov 04 16:06:16 EST 2025 Tue Nov 04 01:58:59 EST 2025 Sun Nov 09 13:21:54 EST 2025 Tue Oct 07 07:05:17 EDT 2025 Thu Apr 03 06:53:28 EDT 2025 Sat Nov 29 04:17:17 EST 2025 Tue Nov 18 21:58:50 EST 2025 Fri Feb 21 02:28:07 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Thyroid autoantibodies Islet autoantibodies Diabetes Graves’ disease |
| Language | English |
| License | Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c564t-44058de9b9b6e5948db8df3b3ce3926d45cb0dc2d766137b056955e1315c3cb13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-4129-1767 |
| OpenAccessLink | https://link.springer.com/10.1007/s12020-019-01852-w |
| PMID | 30783963 |
| PQID | 2205461544 |
| PQPubID | 2043848 |
| PageCount | 7 |
| ParticipantIDs | swepub_primary_oai_portal_research_lu_se_publications_204e6e77_55ce_4f6b_837d_c75f79edd5a7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6454080 proquest_miscellaneous_2184138898 proquest_journals_2205461544 pubmed_primary_30783963 crossref_primary_10_1007_s12020_019_01852_w crossref_citationtrail_10_1007_s12020_019_01852_w springer_journals_10_1007_s12020_019_01852_w |
| PublicationCentury | 2000 |
| PublicationDate | 2019-04-01 |
| PublicationDateYYYYMMDD | 2019-04-01 |
| PublicationDate_xml | – month: 04 year: 2019 text: 2019-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | New York |
| PublicationPlace_xml | – name: New York – name: United States |
| PublicationSubtitle | International Journal of Basic and Clinical Endocrinology |
| PublicationTitle | Endocrine |
| PublicationTitleAbbrev | Endocrine |
| PublicationTitleAlternate | Endocrine |
| PublicationYear | 2019 |
| Publisher | Springer US Springer Nature B.V |
| Publisher_xml | – name: Springer US – name: Springer Nature B.V |
| References | Moriguchi, Noso, Kawabata (CR11) 2011; 60 Ahlqvist, Storm, Karajamaki (CR18) 2018; 6 Ziegler, Hummel, Schenker, Bonifacio (CR2) 1999; 48 Krischer, Lynch, Schatz (CR3) 2015; 58 Achenbach, Hawa, Krause (CR5) 2018; 61 Rogowicz-Frontczak, Zozulilska-Ziolkiewicz, Litwinowicz, Niedzwiecki, Wyka, Wierusz-Wysocka (CR24) 2014; 170 Baekkeskov, Aanstoot, Christgau (CR28) 1990; 347 CR17 Insel, Dunne, Atkinson (CR20) 2015; 38 Haller-Kikkatalo, Pruul, Kisand, Nemvalts, Reimand, Uibo (CR33) 2015; 45 Eisenbarth, Gottlieb (CR7) 2004; 350 Vaziri-Sani, Delli, Elding-Larsson (CR16) 2011; 371 Lantz, Planck, Asman, Hallengren (CR13) 2014; 122 Maugendre, Verite, Guilhem, Genetet, Allannic, Delamaire (CR10) 1997; 137 Jonsdottir, Larsson, Carlsson (CR29) 2017; 102 Allannic, Fauchet, Lorcy (CR32) 1980; 51 Jonsdottir, Andersson, Carlsson (CR23) 2013; 56 Grubin, Daniels, Toivola (CR14) 1994; 37 De Block, De Leeuw, Vertommen (CR30) 2001; 126 Sallorenzo, Silva, Kasamatsu, Dib (CR21) 2017; 61 Li (CR26) 2014; 45 Silva, Sallorenzo, Kater, Dib, Falorni (CR27) 2003; 16 Barbesino, Tomer (CR6) 2013; 98 Payton, Hawkes, Christie (CR15) 1995; 96 Hansen, Matheis, Kahaly (CR1) 2015; 6 Van den Driessche, Eenkhoorn, Van Gaal, De Block (CR8) 2009; 67 Traisk, Tallstedt, Abraham-Nordling (CR12) 2009; 94 Ziegler, Rewers, Simell (CR4) 2013; 309 Hallengren, Falorni, Landin-Olsson, Lernmark, Papadopoulos, Sundkvist (CR9) 1996; 239 Taniyama, Kasuga, Nagayama, Ito (CR19) 2010; 2011 Murgia, Devirgiliis, Mancini, Donadel, Zalewski, Perozzi (CR25) 2009; 19 Wenzlau, Juhl, Yu (CR22) 2007; 104 Graham, Hagopian, Kockum (CR31) 2002; 51 JP Krischer (1852_CR3) 2015; 58 B Hallengren (1852_CR9) 1996; 239 MP Hansen (1852_CR1) 2015; 6 1852_CR17 M Taniyama (1852_CR19) 2010; 2011 D Maugendre (1852_CR10) 1997; 137 GS Eisenbarth (1852_CR7) 2004; 350 MA Payton (1852_CR15) 1995; 96 S Baekkeskov (1852_CR28) 1990; 347 AG Ziegler (1852_CR4) 2013; 309 C Sallorenzo (1852_CR21) 2017; 61 G Barbesino (1852_CR6) 2013; 98 YV Li (1852_CR26) 2014; 45 B Jonsdottir (1852_CR23) 2013; 56 H Allannic (1852_CR32) 1980; 51 B Jonsdottir (1852_CR29) 2017; 102 M Moriguchi (1852_CR11) 2011; 60 RC Silva (1852_CR27) 2003; 16 F Traisk (1852_CR12) 2009; 94 M Lantz (1852_CR13) 2014; 122 A Driessche Van den (1852_CR8) 2009; 67 P Achenbach (1852_CR5) 2018; 61 F Vaziri-Sani (1852_CR16) 2011; 371 C Murgia (1852_CR25) 2009; 19 K Haller-Kikkatalo (1852_CR33) 2015; 45 A Rogowicz-Frontczak (1852_CR24) 2014; 170 AG Ziegler (1852_CR2) 1999; 48 CE Grubin (1852_CR14) 1994; 37 E Ahlqvist (1852_CR18) 2018; 6 CE Block De (1852_CR30) 2001; 126 RA Insel (1852_CR20) 2015; 38 JM Wenzlau (1852_CR22) 2007; 104 J Graham (1852_CR31) 2002; 51 |
| References_xml | – volume: 37 start-page: 344 year: 1994 end-page: 350 ident: CR14 article-title: A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM publication-title: Diabetologia doi: 10.1007/BF00408469 – volume: 2011 start-page: 306487 year: 2010 ident: CR19 article-title: Occurrence of type 1 diabetes in graves' disease patients who are positive for antiglutamic Acid decarboxylase antibodies: an 8-year followup study publication-title: J. Thyroid Res. – volume: 239 start-page: 63 year: 1996 end-page: 68 ident: CR9 article-title: Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment publication-title: J. Intern. Med. Suppl. doi: 10.1046/j.1365-2796.1996.417758000.x – volume: 371 start-page: 25 year: 2011 end-page: 37 ident: CR16 article-title: A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2011.06.011 – volume: 122 start-page: 113 year: 2014 end-page: 117 ident: CR13 article-title: Increased TRAb and/or Low Anti-TPO Titers at Diagnosis of Graves' Disease are Associated with an Increased Risk of Developing Ophthalmopathy after Onset publication-title: Exp. Clin. Endocr. Diab doi: 10.1055/s-0033-1363193 – volume: 309 start-page: 2473 year: 2013 end-page: 2479 ident: CR4 article-title: Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children publication-title: JAMA doi: 10.1001/jama.2013.6285 – volume: 170 start-page: 651 year: 2014 end-page: 658 ident: CR24 article-title: Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes? publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-13-0901 – volume: 347 start-page: 151 year: 1990 end-page: 156 ident: CR28 article-title: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase publication-title: Nature doi: 10.1038/347151a0 – volume: 38 start-page: 1964 year: 2015 end-page: 1974 ident: CR20 article-title: Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association publication-title: Diabetes Care doi: 10.2337/dc15-1419 – volume: 98 start-page: 2247 year: 2013 end-page: 2255 ident: CR6 article-title: Clinical review: clinical utility of TSH receptor antibodies publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2012-4309 – volume: 67 start-page: 376 year: 2009 end-page: 387 ident: CR8 article-title: Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review publication-title: Neth. J. Med. – volume: 350 start-page: 2068 year: 2004 end-page: 2079 ident: CR7 article-title: Autoimmune polyendocrine syndromes publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra030158 – volume: 45 start-page: 178 year: 2014 end-page: 189 ident: CR26 article-title: Zinc and insulin in pancreatic beta-cells publication-title: Endocrine doi: 10.1007/s12020-013-0032-x – volume: 48 start-page: 460 year: 1999 end-page: 468 ident: CR2 article-title: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study publication-title: Diabetes doi: 10.2337/diabetes.48.3.460 – volume: 61 start-page: 361 year: 2017 end-page: 366 ident: CR21 article-title: Prevalence of pancreatic autoantibodies in non-diabetic patients with autoimmune thyroid disease and its relation to insulin secretion and glucose tolerance publication-title: Arch. Endocrinol. Metab. doi: 10.1590/2359-3997000000280 – volume: 94 start-page: 3700 year: 2009 end-page: 3707 ident: CR12 article-title: Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2009-0747 – volume: 104 start-page: 17040 year: 2007 end-page: 17045 ident: CR22 article-title: The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0705894104 – volume: 58 start-page: 980 year: 2015 end-page: 987 ident: CR3 article-title: The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study publication-title: Diabetologia doi: 10.1007/s00125-015-3514-y – volume: 61 start-page: 1644 issue: 7 year: 2018 end-page: 1649 ident: CR5 article-title: Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: action LADA 12 publication-title: Diabetologia doi: 10.1007/s00125-018-4605-3 – volume: 19 start-page: 431 year: 2009 end-page: 439 ident: CR25 article-title: Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands publication-title: Nutr. Metab. Cardiovasc. Dis. doi: 10.1016/j.numecd.2008.09.004 – volume: 16 start-page: 160 year: 2003 end-page: 168 ident: CR27 article-title: Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases publication-title: Diabetes Nutr. Metab. – volume: 51 start-page: 863 year: 1980 end-page: 867 ident: CR32 article-title: HLA and Graves' disease: an association with HLA-DRw3 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-51-4-863 – ident: CR17 – volume: 102 start-page: 1277 year: 2017 end-page: 1285 ident: CR29 article-title: Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis publication-title: J. Clin. Endocrinol. Metab. – volume: 56 start-page: 1735 year: 2013 end-page: 1742 ident: CR23 article-title: Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents publication-title: Diabetologia doi: 10.1007/s00125-013-2934-9 – volume: 6 start-page: 67 year: 2015 end-page: 79 ident: CR1 article-title: Type 1 diabetes and polyglandular autoimmune syndrome: a review publication-title: World J. Diabetes doi: 10.4239/wjd.v6.i1.67 – volume: 96 start-page: 1506 year: 1995 end-page: 1511 ident: CR15 article-title: Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512) publication-title: J. Clin. Invest. doi: 10.1172/JCI118188 – volume: 51 start-page: 1346 year: 2002 end-page: 1355 ident: CR31 article-title: Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes publication-title: Diabetes doi: 10.2337/diabetes.51.5.1346 – volume: 45 start-page: 255 year: 2015 end-page: 262 ident: CR33 article-title: GADA and anti-ZnT8 complicate the outcome of phenotypic type 2 diabetes of adults publication-title: Eur. J. Clin. Invest. doi: 10.1111/eci.12404 – volume: 126 start-page: 236 year: 2001 end-page: 241 ident: CR30 article-title: Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes publication-title: Clin. Exp. Immunol. doi: 10.1046/j.1365-2249.2001.01668.x – volume: 137 start-page: 503 year: 1997 end-page: 510 ident: CR10 article-title: Anti-pancreatic autoimmunity and Graves' disease: study of a cohort of 600 Caucasian patients publication-title: Eur. J. Endocrinol. doi: 10.1530/eje.0.1370503 – volume: 60 start-page: 761 year: 2011 end-page: 766 ident: CR11 article-title: Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity publication-title: Metabolism doi: 10.1016/j.metabol.2010.07.025 – volume: 6 start-page: 361 year: 2018 end-page: 369 ident: CR18 article-title: Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables publication-title: Lancet Diabetes Endocrinology doi: 10.1016/S2213-8587(18)30051-2 – volume: 51 start-page: 863 year: 1980 ident: 1852_CR32 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-51-4-863 – volume: 239 start-page: 63 year: 1996 ident: 1852_CR9 publication-title: J. Intern. Med. Suppl. doi: 10.1046/j.1365-2796.1996.417758000.x – volume: 96 start-page: 1506 year: 1995 ident: 1852_CR15 publication-title: J. Clin. Invest. doi: 10.1172/JCI118188 – volume: 347 start-page: 151 year: 1990 ident: 1852_CR28 publication-title: Nature doi: 10.1038/347151a0 – volume: 56 start-page: 1735 year: 2013 ident: 1852_CR23 publication-title: Diabetologia doi: 10.1007/s00125-013-2934-9 – volume: 38 start-page: 1964 year: 2015 ident: 1852_CR20 publication-title: Diabetes Care doi: 10.2337/dc15-1419 – volume: 60 start-page: 761 year: 2011 ident: 1852_CR11 publication-title: Metabolism doi: 10.1016/j.metabol.2010.07.025 – volume: 126 start-page: 236 year: 2001 ident: 1852_CR30 publication-title: Clin. Exp. Immunol. doi: 10.1046/j.1365-2249.2001.01668.x – volume: 58 start-page: 980 year: 2015 ident: 1852_CR3 publication-title: Diabetologia doi: 10.1007/s00125-015-3514-y – volume: 2011 start-page: 306487 year: 2010 ident: 1852_CR19 publication-title: J. Thyroid Res. – volume: 6 start-page: 361 year: 2018 ident: 1852_CR18 publication-title: Lancet Diabetes Endocrinology doi: 10.1016/S2213-8587(18)30051-2 – volume: 67 start-page: 376 year: 2009 ident: 1852_CR8 publication-title: Neth. J. Med. – volume: 16 start-page: 160 year: 2003 ident: 1852_CR27 publication-title: Diabetes Nutr. Metab. – volume: 37 start-page: 344 year: 1994 ident: 1852_CR14 publication-title: Diabetologia doi: 10.1007/BF00408469 – volume: 122 start-page: 113 year: 2014 ident: 1852_CR13 publication-title: Exp. Clin. Endocr. Diab doi: 10.1055/s-0033-1363193 – volume: 102 start-page: 1277 year: 2017 ident: 1852_CR29 publication-title: J. Clin. Endocrinol. Metab. – volume: 19 start-page: 431 year: 2009 ident: 1852_CR25 publication-title: Nutr. Metab. Cardiovasc. Dis. doi: 10.1016/j.numecd.2008.09.004 – volume: 61 start-page: 361 year: 2017 ident: 1852_CR21 publication-title: Arch. Endocrinol. Metab. doi: 10.1590/2359-3997000000280 – volume: 61 start-page: 1644 issue: 7 year: 2018 ident: 1852_CR5 publication-title: Diabetologia doi: 10.1007/s00125-018-4605-3 – volume: 6 start-page: 67 year: 2015 ident: 1852_CR1 publication-title: World J. Diabetes doi: 10.4239/wjd.v6.i1.67 – volume: 371 start-page: 25 year: 2011 ident: 1852_CR16 publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2011.06.011 – volume: 170 start-page: 651 year: 2014 ident: 1852_CR24 publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-13-0901 – volume: 350 start-page: 2068 year: 2004 ident: 1852_CR7 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra030158 – ident: 1852_CR17 – volume: 45 start-page: 255 year: 2015 ident: 1852_CR33 publication-title: Eur. J. Clin. Invest. doi: 10.1111/eci.12404 – volume: 98 start-page: 2247 year: 2013 ident: 1852_CR6 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2012-4309 – volume: 137 start-page: 503 year: 1997 ident: 1852_CR10 publication-title: Eur. J. Endocrinol. doi: 10.1530/eje.0.1370503 – volume: 45 start-page: 178 year: 2014 ident: 1852_CR26 publication-title: Endocrine doi: 10.1007/s12020-013-0032-x – volume: 48 start-page: 460 year: 1999 ident: 1852_CR2 publication-title: Diabetes doi: 10.2337/diabetes.48.3.460 – volume: 51 start-page: 1346 year: 2002 ident: 1852_CR31 publication-title: Diabetes doi: 10.2337/diabetes.51.5.1346 – volume: 104 start-page: 17040 year: 2007 ident: 1852_CR22 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0705894104 – volume: 94 start-page: 3700 year: 2009 ident: 1852_CR12 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2009-0747 – volume: 309 start-page: 2473 year: 2013 ident: 1852_CR4 publication-title: JAMA doi: 10.1001/jama.2013.6285 |
| SSID | ssj0022267 |
| Score | 2.2696073 |
| Snippet | Purpose
The aim of this work was to investigate, in patients with newly diagnosed Graves’ disease (GD), the frequency of islet autoantibodies including... The aim of this work was to investigate, in patients with newly diagnosed Graves' disease (GD), the frequency of islet autoantibodies including autoantibodies... PurposeThe aim of this work was to investigate, in patients with newly diagnosed Graves’ disease (GD), the frequency of islet autoantibodies including... Purpose: The aim of this work was to investigate, in patients with newly diagnosed Graves’ disease (GD), the frequency of islet autoantibodies including... |
| SourceID | swepub pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 48 |
| SubjectTerms | Adult Autoantibodies Autoantibodies - blood Autoimmune diseases Autoimmunity Beta cells Clinical Medicine Comorbidity Diabetes Diabetes mellitus Diabetes mellitus (insulin dependent) Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - epidemiology Diabetes Mellitus, Type 1 - immunology Diagnosis Endocrinology Endocrinology and Diabetes Endokrinologi och diabetes Female Follow-Up Studies Glutamate decarboxylase Glutamate Decarboxylase - immunology Glutamic acid Graves Disease - blood Graves Disease - diagnosis Graves Disease - epidemiology Graves Disease - immunology Graves' disease Humanities and Social Sciences Humans Insulinoma Internal Medicine Iodide peroxidase Klinisk medicin Male Medical and Health Sciences Medicin och hälsovetenskap Medicine Medicine & Public Health Middle Aged multidisciplinary Original Original Article Peroxidase Prevalence Science Thyroid Thyroid gland Thyroid-stimulating hormone Zinc transporter Zinc Transporter 8 - immunology |
| Title | Prevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves’ disease |
| URI | https://link.springer.com/article/10.1007/s12020-019-01852-w https://www.ncbi.nlm.nih.gov/pubmed/30783963 https://www.proquest.com/docview/2205461544 https://www.proquest.com/docview/2184138898 https://pubmed.ncbi.nlm.nih.gov/PMC6454080 |
| Volume | 64 |
| WOSCitedRecordID | wos000463986100006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLink Journals customDbUrl: eissn: 1559-0100 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022267 issn: 1355-008X databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RghAXHi2PQKmMhLhApE2cxMmxQhQuVIiXVlwsx3baSG2y2mS7LSf-Bhd-HL-EGeexLEWV4BrbmUQzY894Zr4BeBrG2gaJQQ4UNvMjbqhYWWk_skkSBprbxBau2YQ4OEin0-xdXxTWDNnuQ0jS7dSrYreQXJ0JFd1Qxa-_3ICreNylpI7vP3we3Sw0KFxLFTxJfTzhpn2pzN_fsX4cXbAxL6ZKjvHSP7BF3Xm0f-v__uQ23OztT7bXCcwduGKrLdjeq9D3Pjlnz5jLCHVX7Vtw_W0feN-GHwT1pFyBEqsLNtzYMlUZNnMVTN2AWrQ18qrMa8pOZOpQlWh_sq9lpVk74qjPWepWHqLYq5NSM2O1muf12Tna8paplghQBmDZUcAHBcprvWSLGVF5TT2Tmp_fvrM-vnQXPu2_-vjyjd-3dvB1nEStH6GdmBqb5VmeWEKMMXlqCp5zbdFgS0wU63xidGgE2g9c5GimZXFsAx7Emus84Pdgs6or-wCYLSaW40phiigyxqgEp2lNODMiM5n2IBg4LHWPe07tN47lCrGZ-CGRH9LxQy49eD6umXWoH5fO3hkER_Y7QCOpgDlKCOvIgyfjMOouBWRUZesFzkH3OuBpmqUe3O_kbCTHKb6Ku6MHYk0CxwmEC74-UpVHDh-cQNrQEfDgxSB-q8-67C--dPK8TsE5gbJHnjqSxwvZWDn77UpZhhNUbCuEjFHvZVQkuUyRG1KLuBCZNSZW4uG_fcsjuBE69aAMqR3YbOcL-xiu6dO2bOa7sCGm6a5T-l-DcleX |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagIODCo-URKGAkxIVG2sRJnBwrRCmiXSEoaMXF8ittpDZZ7SYs5cTf4MKP45cw4zyWpagSXGM7k2hm7BnPzDeEPA1jbYPEAAdym_kRM1isLLUf2SQJA81sYnPXbIKPx-lkkr3tisLmfbZ7H5J0O_Wy2C1EV2eERTdY8esvLpJLEZxYmMj37v3Hwc0Cg8K1VIGT1IcTbtKVyvz9HavH0Rkb82yq5BAv_QNb1J1HOzf-709ukuud_Um3W4G5RS7Ycp1sbJfge5-c0mfUZYS6q_Z1cmW_C7xvkB8I9SRdgRKtctrf2FJZGjp1FUztgGzqCnhVqAqzE6k8lAXYn_RrUWpaDzjqM5q6lYcg9vKk0NRYLWeq-nIKtrylskYCmAFYtBTgQQ7yWi1oM0Uqr7Bn0vznt--0iy_dJh92Xh682PW71g6-jpOo9iOwE1NjM5WpxCJijFGpyZli2oLBlpgo1mpkdGg42A-MKzDTsji2AQtizbQK2B2yVlalvUeozUeWwUpu8igyxsgEpmmNODM8M5n2SNBzWOgO9xzbbxyLJWIz8kMAP4Tjh1h45PmwZtqifpw7e7MXHNHtAHOBBcxRglhHHnkyDIPuYkBGlrZqYA641wFL0yz1yN1WzgZyDOOrsDt6hK9I4DABccFXR8riyOGDI0gbOAIe2erFb_lZ5_3Fp1aeVyk4J1B0yFNH4rgRcyumv10pi3AEim05FzHovYjyRIkUuCE0j3OeWWNiye__27c8Jld3D_b3xN7r8ZsH5FroVAWzpTbJWj1r7ENyWX-ui_nskVP9X4qkWZM |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB5BQRUXfloKgQJGQlwg6iZO4uRYAQsIWFXiRxUXy7GdNlKbrHazLOXEa3Dh4XgSZpxstktRJcQ1tuNEM7ZnPPN9A_AojLUNEoMSKGzmR9wQWFlpP7JJEgaa28QWrtiEGI3S_f1s7xSK32W7L0KSLaaBWJqqZmdsip0l8C0kt2dAABxC__rzi3ApoqJB5K-__9S7XGhcuPIqeKr6eNrtd7CZv79j9Wg6Y2-eTZvsY6d_8Iy6s2l47f__6jpc7exSttsq0g24YKsN2Nyt0Cc_PmGPmcsUdVfwG7D-rgvIb8JPooBSDrjE6oItbnKZqgwbO2RT26BmTY0yLPOashaZOlAl2qXsW1lp1vT86hOWupEHuBzUcamZsVpN8vrrCdr4lqmGJqDMwLKdAR8UqMf1nM3GNMtLqqU0_fX9B-viTjfh4_DFh2ev_K7kg6_jJGr8CO3H1Ngsz_LEEpOMyVNT8Jxri4ZcYqJY5wOjQyPQruAiR_Mti2Mb8CDWXOcB34K1qq7sbWC2GFiOI4UposgYoxLspjXxz4jMZNqDYCFtqTs-dCrLcSSXTM4kD4nykE4ecu7Bk37MuGUDObf39kKJZLczTCUBm6OEOJA8eNg345qmQI2qbD3DPuh2BzxNs9SDW63O9dNxirvirumBWNHGvgPxha-2VOWh4w0n8jZ0EDx4ulDF5Wed9xefW91encE5h7JjpDqURzM5tXJ86qpZhgNc8FYIGeN-IKMiyWWK0pBaxIXIrDGxEnf-7VsewPre86F8-3r05i5cCd1KoSSqbVhrJjN7Dy7rL005ndx3u8BvtA5idw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+diabetes+and+presence+of+autoantibodies+against+zinc+transporter+8+and+glutamic+decarboxylase+at+diagnosis+and+at+follow+up+of+Graves%E2%80%99+disease&rft.jtitle=Endocrine&rft.au=Jonsdottir%2C+Berglind&rft.au=J%C3%B6nsson%2C+Ida&rft.au=Lantz%2C+Mikael&rft.date=2019-04-01&rft.pub=Springer+US&rft.issn=1355-008X&rft.eissn=1559-0100&rft.volume=64&rft.issue=1&rft.spage=48&rft.epage=54&rft_id=info:doi/10.1007%2Fs12020-019-01852-w&rft.externalDocID=10_1007_s12020_019_01852_w |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-008X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-008X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-008X&client=summon |